High cocoa polyphenol rich chocolate may reduce the burden of the symptoms in chronic fatigue syndrome by Sathyapalan, T. et al.
RESEARCH Open Access
High cocoa polyphenol rich chocolate may
reduce the burden of the symptoms in chronic
fatigue syndrome
Thozhukat Sathyapalan1,2*, Stephen Beckett3, Alan S Rigby4, Duane D Mellor2, Stephen L Atkin1,2
Abstract
Background: Chocolate is rich in flavonoids that have been shown to be of benefit in disparate conditions
including cardiovascular disease and cancer. The effect of polyphenol rich chocolate in subjects with chronic
fatigue syndrome (CFS) has not been studied previously.
Methods: We conducted a double blinded, randomised, clinical pilot crossover study comparing high cocoa
liquor/polyphenol rich chocolate (HCL/PR) in comparison to simulated iso-calorific chocolate (cocoa liquor free/low
polyphenols(CLF/LP)) on fatigue and residual function in subjects with chronic fatigue syndrome. Subjects with CFS
having severe fatigue of at least 10 out of 11 on the Chalder Fatigue Scale were enrolled. Subjects had either
8 weeks of intervention in the form of HCL/PR or CLF/LP, with a 2 week wash out period followed by 8 weeks of
intervention with the other chocolate.
Results: Ten subjects were enrolled in the study. The Chalder Fatigue Scale score improved significantly after
8 weeks of the HCL/PR chocolate arm [median (range) Exact Sig. (2-tailed)] [33 (25 - 38) vs. 21.5 (6 - 35) 0.01], but
that deteriorated significantly when subjects were given simulated iso-calorific chocolate (CLF/CP) [ 28.5 (17 - 20)
vs. 34.5 (13-26) 0.03]. The residual function, as assessed by the London Handicap scale, also improved significantly
after the HCL/PR arm [0.49 (0.33 - 0.62) vs. 0.64 (0.44 - 0.83) 0.01] and deteriorated after iso-calorific chocolate
[00.44 (0.43 - 0.68) vs. 0.36 (0.33 - 0.62)0.03]. Likewise the Hospital Anxiety and Depression score also improved after
the HCL/PR arm, but deteriorated after CLF/CP. Mean weight remained unchanged throughout the trial.
Conclusion: This study suggests that HCL/PR chocolate may improve symptoms in subjects with chronic fatigue
syndrome.
Background
Chronic fatigue syndrome (CFS) is a debilitating condi-
tion with high morbidity and an associated reduced
quality of life[1]. Surveys examining the prevalence of
CFS have reported prevalence rates ranging from 0.2%
to 2.6% in primary care populations [2]. Various thera-
pies including antidepressants, cognitive behaviour ther-
apy and graded exercise therapy have been tried in CFS
with varying effects [3].
Cocoa contains a complex mixture of polyphenols
especially flavonoids. Observational studies report that
dietary flavonoids may reduce the mortality risk from
coronary heart disease, cancer and stroke [4,5]. Experi-
mental studies on animals and cultured human cell lines
have demonstrated the role of polyphenols in the pre-
vention of cardiovascular diseases, cancers, neurodegen-
erative diseases, diabetes and osteoporosis [6]. The effect
of chocolate on fatigue appears to have been first
described by the Aztec Emperor Montezuma II (born
c.1480 reigned 1502-1520) who noted, “The divine
drink, which builds up resistance and fights fatigue. A
cup of this precious drink [cocoa] permits man to walk
for a whole day without food’’. The Badianus Codex
(1552) noted the use of cocoa flowers to treat fatigue
[7]. Chocolate is known to increase neurotransmitters
like phenyl ethylamine, serotonin, and anandamide in
the brain [8]. An imbalance in various neurotransmitters
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including serotonin have also been reported in subjects
with CFS [9]. The effect of cocoa in subjects with
chronic fatigue syndrome has not been studied to date.
We hypothesised that chocolate, by modulating neuro-
transmitters, might reduce the symptom burden of CFS.
Therefore, we conducted a double blinded, randomised,
clinical pilot crossover study comparing high cocoa
liquor/polyphenol rich chocolate to simulated iso-
calorific chocolate (cocoa liquor free/low polyphenols)
on fatigue and residual function in subjects with chronic
fatigue syndrome.
Materials and methods
Ten consecutive subjects with chronic fatigue syndrome
from a secondary care setting who fulfilled the exclu-
sion and inclusion criteria were recruited in this study.
The Centres for Disease Control and Prevention criteria
were used to diagnose Chronic Fatigue syndrome [10].
Subjects having severe fatigue of at least 10 out of 11
on the Chalder Fatigue Scale (binary scored) were
enrolled [11].
The exclusion criteria were: any co-morbid psychiatric
disorder classified according to Diagnostic and Statistical
Manual of Mental Disorders (fourth edition) (DSM IV)
criteria (APA 1984), subjects taking more than 10 gm of
chocolate per day, use of any prescription medication
including benzodiazepine or antidepressant drugs, over
the counter medications including herbal remedies two
months before study entry, and an inability to attend
the hospital for screening tests or follow-up visits.
All participants gave their written informed consent
prior to participating in the study. The study was
approved by the Hull and East Riding Local Research
Ethics Committee. Block randomisation was performed.
Subjects had 8 weeks of the initial intervention and then
8 weeks of the crossover intervention separated by a
2 week wash out between the 2 arms. Severity of fatigue
and handicap was analysed using using validated self-
report questionnaires (Chalder Fatigue Scale (Likert
Scored), the London Handicap Scale (LHS) and the
Hospital Anxiety and Depression Scale before and after
each phase of the trial [11-13].
The active product was polyphenol rich chocolate
containing 85% cocoa solids (derived from a high cocoa
liquor content) compared with chocolate containing
cocoa butter alone that contained no non-fat cocoa
solids (cocoa liquor) (simulated iso-calorific chocolate).
Chocolate containing cocoa butter alone was dyed to
the same colour as the high cocoa liquor/polyphenol
rich chocolate (with a recipe specially prepared by Nes-
tlé PLC York. UK). Individual 15 g foil wrapped bars
were provided and subjects were asked to consume 1
bar three times daily. Subjects were reviewed by the
dietician during screening, before and after each
intervention to assess whether they were taking more
than 10 g of chocolate per day prior to recruitment, as
well as to advise them not to consume extra chocolate
during the study period. Apart from this, subjects were
advised not to change their diet. A taste trial was per-
formed prior to the study to confirm that subjects could
not distinguish between the two treatments.
Analysis of the chocolate was performed by Nestlé
PLC York. The simulated iso-calorific chocolate with
the dye contained 547 Kilocalories/100 g where as the
dark chocolate with cocoa powder contained 545 kilo-
calories/100 g (’’Genesis for Windows, Esha Research’’
software). The glycaemic index of dark chocolate was 41
where as for simulated iso-calorific chocolate was 40.
The composition of high cocoa liquor/polyphenol rich
chocolate and the simulated iso-calorific chocolate is
given in Table 1, and the polyphenol content of each
shown in Table 2. The total percentage of non-fat cocoa
solids (cocoa liquor) in polyphenol rich chocolate was
33.17%. Micro analyses were carried out on a cross sec-
tion of samples resulting in no salmonella or enterobac-
ter laceae.
Statistical Methods
We calculated sample size according to previous pub-
lished data on the fatigue scale in chronic fatigue syn-
drome[14]. With a confidence interval of 1-alpha (2
sided), and a standard deviation of 2.25, for 80% power
that gave a number of 10 subjects to be studied to show
a 4 point difference between the two treatments includ-
ing a drop out rate of 2 subjects. Statistical analysis was
performed using SPSS for Windows NT, version 9.0
(SPSS Inc., Chicago, Illinois). Data was analyzed on an
‘intention to treat’ basis with the Wilcoxon Signed Rank
sum test before and after intervention. An arbitrary level
of 5% statistical significance was assumed (two tailed).
Successful demonstration of efficacy for the trial was
defined as a statistically significant superiority over
cocoa absent chocolate in the primary outcome variable,
fatigue.
Results
Ten subjects (6 females and 4 males) were enrolled in
the study. The mean age of subjects was (mean ± SD)
52 ± 8 years and mean body mass index was 28.3 ± 2
kg/m2. The Chalder Fatigue Scale score improved signif-
icantly after 8 weeks of the active high cocoa polyphenol
rich chocolate phase, however these scores deteriorated
significantly when subjects were given simulated iso-
calorific cocoa liquor free/low polyphenol chocolate
(Table 3). The residual function, as assessed by the Lon-
don Handicap scale, also improved significantly after the
active phase and deteriorated during the placebo phase
(Table 3). A similar trend was also found in HAD scale.
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Anecdotally, two subjects were able to return back to
work after having had their symptoms for a 2 year per-
iod and chose to continue on a high cocoa solid choco-
late diet.
The mean weight before and after the high cocoa cho-
colate intervention were unchanged at 77.04 kg and
76.80 kg, respectively (p value - 0.326). The mean
weight before and after the placebo intervention were
also unchanged (73.43 kg vs. 73.85 kg, respectively
p value 0.345).
Discussion
This study shows that high cocoa polyphenol rich cho-
colate reduced the burden of symptoms in subjects in
chronic fatigue syndrome. As both types of chocolate
were iso-calorific and had similar glycemic indices and
loads, it is likely that the improvement was due to the
high polyphenol content within the active chocolate,
rather than a difference in of the micro or macronutri-
ent the composition of the two chocolates. The signifi-
cance of the results is particularly surprising because of
the small number of subjects in the study.
It is also interesting to note that there was no signifi-
cant weight change after both phases of the study
despite consuming an extra 245 Kcal daily for each two
month period. The potential weight gain may have been
offset by improvement in functional status and physical
activity when they had high cocoa polyphenol rich cho-
colate. However, this would not explain why the weight
was unchanged in the placebo group, particularly as
they reported an increase in their fatigue.
Arachidonyl ethanolamide, later called anandamide (a
name that comes from ananda, the Sanskrit word for
‘’bliss’’) has a structural similarity with tetrahydrocanni-
bol, and other strongly related compounds that are
found in cocoa [8]. There are also compounds (N-acy-
lethanolamines) that block the breakdown of ananda-
mide in cocoa [8]. It may be the synergy of these
compounds in chocolate that may account for the
results seen in this study.
A number of biological systems have been implicated
in chronic fatigue syndrome and there is mounting evi-
dence that oxidative stress [15-18] contributes to the
disease process and to some of the symptoms in the ill-
ness [19]. Flavanoids have shown to have a protective
effect on cells including neuronal cells from oxidative
stress [20]; however, this mechanism needs to be
explored in further studies.
Table 1 Composition of high cocoa liquor/polyphenol rich chocolate and simulated iso-calorific chocolate (cocoa
liquor free/low polyphenol)
Composition by
ingredient
High Cocoa Liquor Polyphenol Rich
chocolate
%
Simulated iso-calorific
chocolate (Cocoa Liquor
Free/Low Polyphenol)
%
Cocoa liquor (non fat) 68.10 00.00
Sugar 22.64 43.39
Whole milk powder 00.00 27.05
Cocoa butter 06.42 20.01
Whey powder 00.00 04.95
Vegetable fat 00.00 04.34
Butter fat 02.45 00.00
Lecithin 00.34 00.21
Vanillin 00.05 00.05
Composition by Macronutrient % %
Protein 5.43 5.72
Carbohydrate 19.51 41.78
Fat 75.05 52.44
Table 2 Polyphenol analysis* high cocoa liquor/
polyphenol rich chocolate and simulated iso-calorific
chocolate (cocoa liquor free/low polyphenol)
High Cocoa Liquor/
Polyphenol
Rich chocolate
Simulated iso-calorific
chocolate
(Cocoa Liquor Free/
Low
Polyphenol)
Polyphenols
Folin 17.4 mg ECE/g 3.9 mg ECE/g
Catechin 0.37 g/kg <0.05 g/kg
Dimer B2 0.80 g/kg <0.05 g/kg
Epicatechin 1.23 g/kg <0.05 g/kg
Trimer C 0.58 g/kg <0.05 g/kg
Tetramer D 0.33 g/kg <0.05 g/kg
Dimer B5 0.32 g/kg <0.05 g/kg
*Analysed by Nestlé UK Quality Assurance Laboratory
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Despite the positive findings, this study is still limited
due the small number of participants and larger studies
are necessary to confirm these findings.
As this was a proof of concept study; physical activity
was not formally assessed. Biochemical markers includ-
ing plasma polyphenol levels and inflammatory markers
were not measured as part of the study as all of the
baseline parameters prior to the study were normal, in
accord with the criteria for the diagnosis of chronic fati-
gue syndrome.
Since there was a consistent improvement of symp-
toms with high cocoa phenol chocolate and deteriora-
tion with iso-calorific chocolate, a placebo effect is
unlikely. Moreover, the taste panel of healthy people
before the study could not differentiate the taste
between high cocoa and iso-calorific chocolate.
In summary, this study suggests that consuming high
cocoa polyphenol rich chocolate 15 g three times daily
has a beneficial effect in improving fatigue and residual
function in subjects with CFS over a period of 8 weeks
compared to simulated iso-calorific cocoa mass free/low
polyphenol chocolate. This may be of benefit for sub-
jects with CFS if included as part of a healthy diet or in
a formal treatment protocol.
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